C4 Therapeutics, Inc. earnings per share and revenue

CCCC earnings per share for the last quarter are -0.41 USD whereas the estimation was -0.36 USD which accounts for -12.37% surprise. Company revenue for the same period amounts to 3.04 M USD despite the estimated figure of 11.99 M USD. Estimated earnings per share for the next quarter are -0.45 USD, and revenue is expected to reach 4.81 M USD. Also watch annual changes over time to get a bigger picture of CCCC earnings per share and revenue dynamics.